ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) (Q73758085)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2003

Language	Label	Description	Also known as
English	ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML)	scientific article published on 01 August 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

ATG as part of the conditioning regimen reduces transplant-related mortality (TRM) and improves overall survival after unrelated stem cell transplantation in patients with chronic myelogenous leukemia (CML) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

stem cell transplantation

1 reference

based on heuristic

inferred from title

Martin Bornhäuser

9

object named as

Bornhäuser M

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Gerhard Ehninger

10

object named as

Ehninger G

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

Zander AR

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kröger N

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schleuning M

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Finke J

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Zabelina T

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Beelen D

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schwerdtfeger R

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Baurmann H

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fauser AA

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kiehl M

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Trenschel R

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Ottinger HD

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bertz H

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Berger J

16

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Kolb HJ

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Schaefer UW

18

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

355-361

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12900771%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Marrow transplantation for the treatment of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell-depleted bone marrow transplantation and delayed T cell add-back to control acute GVHD and conserve a graft-versus-leukemia effect

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-thymocyte-globulin as part of the preparative regimen prevents graft failure and severe graft versus host disease (GvHD) in allogeneic stem cell transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation from unrelated donors using in vivo anti-T-cell globulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomenclature for factors of the HLA system, 1994.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Definition of HLA-DQ as a transplantation antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide/antithymocyte globulin conditioning of patients with severe aplastic anemia for marrow transplantation from HLA-matched siblings: Preliminary results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring anti-thymocyte globulin (ATG) in bone marrow recipients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Jurkat cell-reactive anti-thymocyte globulin assessed ex vivo by flow cytometry persists three weeks in circulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogeneic PBSCT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab in stem cell transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704157

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73758085&oldid=2220072036"